Symyx Named Top 10 Life Science Software Vendor by IDC's Health Industry Insights

29-Jun-2009 - USA

Flexibility and precision: chromatography columns for every application

High-performance ion exchange resins for biochromatography

Seamlessly Digitize Your Quality Management

Symyx Technologies, Inc. has announced it has been named one of the Top 10 life science Software Vendors in a May 2009 report published by Health Industry Insights, an IDC company.

"The inclusion of specialty vendors in the enterprise life science software top 10 list reflects significant growth trends impacting the industry," said Alan S. Louie, Ph.D., research director, Health Industry Insights. "The conversion from paper-based efforts to electronic systems to improve collection, analysis and accessibility is driving vendor growth across the pharmaceutical value chain, including rapid growth in electronic notebooks."

https://www.bionity.com/en/news/102577/symyx-named-top-10-life-science-software-vendor-by-idc-s-health-industry-insights.html

Topics

life science

Show all

Organizations

Symyx Technologies

Maximum binding capacity in ion exchange chromatography

ImageQuant TL analysis software

Accurate and compliant seal strength and leak testing on all types of packages

Last viewed contents

Genzyme and Isis Announce Submission of European Marketing Authorization Application for Mipomersen (Kynamro) - Submission Seeks Approval for Mipomersen’s Use in the Treatment of Homozygous Familial Hypercholesterolemia and Severe Heterozygous Familial Hypercholesterolemia

Go to page

Former Merck CEO appointed Chair of the AiCuris Supervisory Board

Go to page

Novavax and Bharat Biotech announce a pandemic influenza vaccine development alliance

Go to page

Effectiveness of drug to improve natriuretic peptide levels for chronic heart failure

Go to page

To-BBB receives International Innovation grant to support partnership with top-5 pharma company

Go to page

Lundbeck starts clinical phase IIa with Lu AA24493 (cEPO) in Friedreich's ataxia

Go to page

More from the department business & finance Subscribe to newsletter

Get the life science industry in your inbox

Symyx Named Top 10 Life Science Software Vendor by IDC's Health Industry Insights

Bayer opens first Co.Lab Life science incubator in Cambridge

Other news from the department business & finance

Merck Acquires JSR Chromatography Business

Novartis agrees to acquire Excellergy, Inc.

Growth in visitor numbers, full halls, clear future topics: analytica 2026 sets standards

Cellbricks Therapeutics Raises €10 Million New Capital to Move Living Tissue Implants Toward the Clinic

Berlin names Health Innovation Quarter Berlin-Mitte the new place of the future

US pharmaceutical company Merck is acquiring Terns Pharmaceuticals for around $6.7 billion

Rentschler Biopharma completes the largest expansion in the company’s history in the US

Evonik shortens the path from research to market readinessEvonik launches Innovation Factory

VTU Engineering Germany gets new managing director

German analysis and laboratory industry cautiously optimistic about the current year

Automation and robotics drive growth in the laboratory

Roche launches AI initiative to tackle lengthy development times

Sartorius is counting on a biopharma boom by 2030

Biotech start-up secures €23 million total for cancer and infectious disease platform

German biotech company chooses Saxony-Anhalt for protein production facility

Nine million euros for innovative cancer therapy

Tecan aims to bring unused lab data to life with NVIDIA

Start-up AveThera acquires Fraunhofer site for biologics production

Chemicals still in trouble

​​​3 questions to Susanne Grödl: AI and digital transformation shape analytica 2026

Get the life science industry in your inbox

Most read news

Start-up AveThera acquires Fraunhofer site for biologics production

BioNTech co-founders establish new biotech company

Plastic bottles turned into Parkinson’s medication

How old are we really?

More meat, lower risk of dementia: study reveals gene-dependent effect

Already approved drug is effective against aggressive brain tumors

Roche grows against the trend and invests over 700 million euros in Germany

Roche launches AI initiative to tackle lengthy development times

Failed experiment by Cambridge scientists leads to surprise drug development breakthrough

Disastrous interplay: protein uncovered that makes cancer grow faster

Vascular killer LDL cholesterol: are butter, eggs and cheese the culprits?

Vitamin B2 deficiency makes cancer cells more susceptible to programmed cell death

More news from our other portals

AI rebuilds molecules from exploding fragments

German food tech company secures €8 million to combat food waste

Non-destructive battery testing: New method developed

A flexible electrolyte for solid batteries

Amazonian cocoa could become a superfood

Chemical industry at a turning point: six keys to transformation

Why does oat milk sometimes foam perfectly and sometimes not at all?

WACKER cuts over 1,500 jobs to reduce costs by €300 million

How climate-friendly is insect protein really?

CO2 to E-Methanol, Aviation Fuels and Speciality Chemicals

How can startups revolutionize home cooking?

How a 270-year-old physics trick could supercharge affordable battery technology

Research team achieves breakthrough in breeding winter-hardy faba beans

BAM, HZB and HU are conducting joint research on sodium batteries

Tailor-made New Battery Materials

Energy storage breakthrough solves the fast-charging problem

How is refrigerator insulation turned back into high-quality MDI?

Last viewed contents

Genzyme and Isis Announce Submission of European Marketing Authorization Application for Mipomersen (Kynamro) - Submission Seeks Approval for Mipomersen’s Use in the Treatment of Homozygous Familial Hypercholesterolemia and Severe Heterozygous Familial Hypercholesterolemia

Former Merck CEO appointed Chair of the AiCuris Supervisory Board

Novavax and Bharat Biotech announce a pandemic influenza vaccine development alliance

Effectiveness of drug to improve natriuretic peptide levels for chronic heart failure

To-BBB receives International Innovation grant to support partnership with top-5 pharma company

Lundbeck starts clinical phase IIa with Lu AA24493 (cEPO) in Friedreich's ataxia

3 questions to Susanne Grödl: AI and digital transformation shape analytica 2026